Lead Product(s) : Loperamide Hydrochloride,Simethicone
Therapeutic Area : Gastroenterology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Granules India Limited Received ANDA Approval for Loperamide HCl and Simethicone Tablets
Details : Generic of Loperamide Hydrochloride and Simethicone Tablets have been approved which is indicated to relieve symptoms of diarrhea plus bloating, pressure and cramps, commonly referred to as gas.
Product Name : Imodium Multi-Symptom Relief-Generic
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 30, 2022
Lead Product(s) : Loperamide Hydrochloride,Simethicone
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Simethicone
Therapeutic Area : Gastroenterology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Wonderbelly Expands Digestive Health Medicines with Launch of Bloat + Gas Relief Product
Details : Bloat + Gas Relief (simethicone) is a USFDA approved antifoaming agent which is indicated for the treatment of bloating, gas discomfort, abdominal pressure, and associated fullness.
Product Name : Bloat + Gas Relief
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 04, 2024
Lead Product(s) : Simethicone
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Simethicone
Therapeutic Area : Gastroenterology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety of Two Simeticone Brands in Adults With Functional Dyspepsia
Details : Undisclosed
Product Name : Imonogas
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 21, 2016
Lead Product(s) : Simethicone
Therapeutic Area : Gastroenterology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Simethicone
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Biogen
Deal Size : Inapplicable
Deal Type : Inapplicable
Pilot Study to Assess Dimethyl Fumarate Related GI Symptom Mitigation
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 15, 2014
Lead Product(s) : Simethicone
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Biogen
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Simethicone
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : GE Healthcare
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 13, 2013
Lead Product(s) : Simethicone
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : GE Healthcare
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
